Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) CFO T Christopher Uchida sold 2,103 shares of the firm’s stock in a transaction dated Wednesday, January 28th. The shares were sold at an average price of $119.88, for a total value of $252,107.64. Following the sale, the chief financial officer owned 11,473 shares in the company, valued at $1,375,383.24. This trade represents a 15.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
T Christopher Uchida also recently made the following trade(s):
- On Tuesday, November 18th, T Christopher Uchida sold 782 shares of Palomar stock. The shares were sold at an average price of $128.84, for a total transaction of $100,752.88.
Palomar Stock Up 0.3%
Shares of NASDAQ PLMR opened at $123.59 on Friday. The company’s 50-day simple moving average is $127.65 and its 200-day simple moving average is $123.83. Palomar Holdings, Inc. has a 52-week low of $104.47 and a 52-week high of $175.85. The firm has a market cap of $3.28 billion, a price-to-earnings ratio of 19.28 and a beta of 0.42.
Trending Headlines about Palomar
Here are the key news stories impacting Palomar this week:
- Neutral Sentiment: Yahoo Finance published a piece asking whether PLMR’s recent price slide creates a long‑term buying opportunity — a constructive framing for value investors but speculative. Is Palomar Holdings (PLMR) Price Slide Creating A Long Term Opportunity For Investors
- Negative Sentiment: CEO Mac Armstrong sold 11,484 shares at $119.88 (≈$1.38M); his post-sale holding is 91,737 shares (11.13% decrease). SEC filing: CEO Sale Filing
- Negative Sentiment: President Jon Christianson sold 1,991 shares at $119.88 (≈$238.7k); post-sale holding 62,985 shares (3.06% decrease). SEC filing: President Sale Filing
- Negative Sentiment: CFO T. Christopher Uchida sold 2,103 shares at $119.88 (≈$252.1k); post-sale holding 11,473 shares (15.49% decrease). SEC filing: CFO Sale Filing
- Negative Sentiment: Insider Jonathan Knutzen sold 1,535 shares at $119.88 (≈$184.0k); post-sale holding 24,809 shares (5.83% decrease). SEC filing: Insider Sale Filing
- Negative Sentiment: Insider Angela L. Grant sold 1,447 shares at $119.88 (≈$173.5k); post-sale holding 5,242 shares (21.63% decrease). SEC filing: Insider Sale Filing
Wall Street Analyst Weigh In
PLMR has been the subject of a number of research analyst reports. JPMorgan Chase & Co. raised their target price on Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Wednesday, January 7th. Wall Street Zen raised shares of Palomar from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. Keefe, Bruyette & Woods upped their target price on shares of Palomar from $170.00 to $171.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 6th. Finally, Weiss Ratings raised shares of Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, January 14th. Six investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $159.50.
Read Our Latest Research Report on PLMR
Hedge Funds Weigh In On Palomar
A number of institutional investors have recently modified their holdings of the business. PVG Asset Management Corp purchased a new position in Palomar in the 4th quarter valued at $218,000. Pictet Asset Management Holding SA boosted its stake in shares of Palomar by 10.1% during the 4th quarter. Pictet Asset Management Holding SA now owns 4,440 shares of the company’s stock worth $598,000 after acquiring an additional 408 shares in the last quarter. Kickstand Ventures LLC. purchased a new stake in Palomar during the fourth quarter worth $315,000. Vanguard Group Inc. boosted its position in shares of Palomar by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 2,698,278 shares of the company’s stock worth $363,620,000 after buying an additional 67,038 shares in the last quarter. Finally, Calamos Advisors LLC acquired a new stake in shares of Palomar in the fourth quarter valued at approximately $2,344,000. 90.25% of the stock is owned by institutional investors and hedge funds.
About Palomar
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
See Also
- Five stocks we like better than Palomar
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
